Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The clinical trial study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T20:23:08.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.3%
    Check dated 2026-10-17T22:00:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site release identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.3%
    Check dated 2026-10-10T22:00:52.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the full study record with an error page. This blocks access to the trial's overview, eligibility criteria, locations, and outcomes.
    Difference
    17%
    Check dated 2026-09-19T20:58:41.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Status on the study page updated to 'Results Submitted' from 'No Results Posted'. This indicates the trial's results have been submitted for review and will appear in the results section.
    Difference
    0.0%
    Check dated 2026-09-05T19:29:17.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.5 to v3.6.6. This indicates a minor update to the page's version metadata rather than any content changes.
    Difference
    0.0%
    Check dated 2026-08-29T19:14:10.000Z thumbnail image

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.